Novo Nordisk Scraps Rare-Disease Factory, Bets on Oral Obesity Pill and CagriSema to Revive Growth
Novo Nordisk pivots from rare diseases to obesity, scrapping a Danish plant and 400 jobs, as it races…
Novo Nordisk Broadens GLP 1 Story With Pediatric And Rare Disease Gains
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
Novo Nordisk Rare Disease Wins Add Context To Undervalued Share Price
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…